Difficulty: Medium
Average Score: 67%
Practice
The rare but characteristic adverse effect of HMG-CoA reductase inhibitors is
Correct answer
B
Rationale
In this question, the correct answer is B) Myopathy. HMG-CoA reductase inhibitors, also known as statins, are commonly prescribed for lowering cholesterol levels. Myopathy is a rare but well-documented adverse effect of statin therapy. It presents as muscle pain, weakness, or tenderness, and in severe cases, can progress to rhabdomyolysis, a serious condition where muscle breakdown products can lead to kidney damage.
Option A) Onycolysis, which is the separation of the nail plate from the nail bed, is not a characteristic adverse effect of HMG-CoA reductase inhibitors.
Option C) Alopecia, or hair loss, is not a known adverse effect of statins.
Option D) Oculomucocutaneous syndrome is not associated with HMG-CoA reductase inhibitors. This term refers to a rare condition involving the eyes, mucous membranes, and skin, typically seen in reaction to certain medications or infections.
Educationally, understanding the adverse effects of medications is crucial for healthcare professionals to make informed decisions when prescribing or monitoring patients on these medications. Recognizing the potential adverse effects of statins, such as myopathy, allows for early detection, management, and prevention of serious complications, ultimately enhancing patient safety and outcomes.
Option A) Onycolysis, which is the separation of the nail plate from the nail bed, is not a characteristic adverse effect of HMG-CoA reductase inhibitors.
Option C) Alopecia, or hair loss, is not a known adverse effect of statins.
Option D) Oculomucocutaneous syndrome is not associated with HMG-CoA reductase inhibitors. This term refers to a rare condition involving the eyes, mucous membranes, and skin, typically seen in reaction to certain medications or infections.
Educationally, understanding the adverse effects of medications is crucial for healthcare professionals to make informed decisions when prescribing or monitoring patients on these medications. Recognizing the potential adverse effects of statins, such as myopathy, allows for early detection, management, and prevention of serious complications, ultimately enhancing patient safety and outcomes.